About company
Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
- US 4685 runway street
- Unknown
- Unknown
- glycominds.com
- Not verified company
